/TRSSF
TRSSF Stock - TerrAscend Corp.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$1.72-11.79%
$0.23 (-11.79%) • Jul 5
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.69
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.40
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+138.4%upside
Target: $4.10
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for TRSSF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.70 – $1.74
TARGET (TP)$4.10
STOP LOSS$1.58
RISK/REWARD1:17.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.00
52W High$3.09
52W Low$1.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $306.68M | $317.33M | $247.83M | $194.21M | $198.32M |
| Gross Profit | $149.96M | $159.70M | $101.50M | $115.97M | $26.34M |
| Gross Margin | 48.9% | 50.3% | 41.0% | 59.7% | 13.3% |
| Operating Income | $-1,198,000 | $-22,996,000 | $-335,915,000 | $22.91M | $-49,259,000 |
| Net Income | $-80,232,000 | $-91,101,000 | $-395,710,084 | $12.63M | $-139,204,000 |
| Net Margin | -26.2% | -28.7% | -159.7% | 6.5% | -70.2% |
| EPS | $-0.28 | $-0.33 | $-1.24 | $0.07 | $-0.83 |
Company Overview
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. In addition, it owns various synergistic under Gage Cannabis, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. brands. As of July 26, 2022, the company operated 27 dispensaries, including 3 Cookies dispensaries in Michigan and 1 in Toronto. TerrAscend Corp. was incorporated in 2017 and is headquartered in Mississauga, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
TRSSFBeat Rate
31%
Last 13 quarters
Avg Surprise
-840.1%
EPS vs Estimate
Beats / Misses
4/9
Last 12 quarters
Latest EPS
$-0.03
Q2 2025
EPS Surprise History
Q3 23
-91.8%
$-0.06vs$-0.03
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q1 25
No data
Q2 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | May 8, 2025 | — | $-0.03 | — | — |
Q1 2025 | Mar 6, 2025 | — | $-0.04 | — | — |
Q3 2024 | Sep 30, 2024 | — | $-0.06 | — | — |
Q2 2024 | Jun 30, 2024 | — | $-0.02 | — | — |
Q2 2024 | May 9, 2024 | — | $-0.06 | — | — |
Q1 2024 | Mar 14, 2024 | — | $-0.16 | — | — |
Q4 2023 | Nov 13, 2023 | — | $-0.04 | — | — |
Q3 2023 | Aug 10, 2023 | $-0.03 | $-0.06 | -91.8% | ✗ MISS |
Q2 2023 | May 11, 2023 | $-0.03 | $-0.08 | -134.8% | ✗ MISS |
Q1 2023 | Mar 16, 2023 | $0.02 | $0.05 | +225.1% | ✓ BEAT |
Q4 2022 | Nov 14, 2022 | $-0.06 | $0.07 | +216.7% | ✓ BEAT |
Q3 2022 | Aug 11, 2022 | $-0.04 | $-0.13 | -203.5% | ✗ MISS |
Q2 2022 | May 12, 2022 | $-0.03 | $-0.05 | -100.0% | ✗ MISS |
Q1 2022 | Mar 16, 2022 | $-0.01 | $-0.03 | -233.3% | ✗ MISS |
Q4 2021 | Nov 16, 2021 | $0.01 | $0.28 | +1966.4% | ✓ BEAT |
Q3 2021 | Aug 19, 2021 | $-0.01 | $-0.14 | -1239.7% | ✗ MISS |
Q2 2021 | May 19, 2021 | $-0.01 | $-0.10 | -631.0% | ✗ MISS |
Q1 2021 | Feb 19, 2021 | $-0.01 | $-0.73 | -11045.0% | ✗ MISS |
Q4 2020 | Nov 19, 2020 | $0.01 | $0.04 | +400.0% | ✓ BEAT |
Q3 2020 | Aug 19, 2020 | $-0.02 | $-0.03 | -50.0% | ✗ MISS |
Latest News
Loading news...
Frequently Asked Questions about TRSSF
What is TRSSF's current stock price?
TerrAscend Corp. (TRSSF) is currently trading at $1.72 per share. The stock has moved -11.79% today.
What is the analyst price target for TRSSF?
The average analyst price target for TRSSF is $4.10, based on 1 analyst.
What sector is TerrAscend Corp. in?
TerrAscend Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is TRSSF's market cap?
TerrAscend Corp. has a market capitalization of $0.60 billion, making it a small-cap company.
Does TRSSF pay dividends?
No, TerrAscend Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAIHLF
Adcock Ingram Holdings Limited
$3.50
Mkt Cap: $0.6B
CCHWF
Columbia Care Inc.
$0.94
Mkt Cap: $0.5B
CKDXF
Opthea Limited
$0.44
Mkt Cap: $0.5B
CLAZF
Claritas Pharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
CSWYF
China Shineway Pharmaceutical Group Limited
$1.00
Mkt Cap: $0.8B
IVEVF
Inventiva S.A.
$4.44
Mkt Cap: $0.6B
KDGTF
Kindstar Globalgene Technology, Inc.
$0.68
Mkt Cap: $0.7B
PEXXF
PT Tempo Scan Pacific Tbk
$0.09
Mkt Cap: $0.5B
PKBFF
PeakBirch Commerce Inc.
$0.00
Mkt Cap: $0.5B
XVIPY
Xvivo Perfusion AB (publ)
$4.60
Mkt Cap: $0.6B
Explore stocks similar to TRSSF for comparison